FDA Approves Lipfendra, the First Daily Pill of Its Kind to Lower Bad Cholesterol

Lipfendra (enlicitide) is a new prescription medicine approved by the FDA. It is used along with a healthy diet and exercise to help lower bad cholesterol in adults. This includes adults who have an inherited… Read more

Ryaltris Nasal Spray Now Approved for Kids Ages 6-11 With Seasonal Allergies

The FDA has approved Ryaltris nasal spray for children ages 6 to 11 years who have seasonal allergies. Seasonal allergies can cause a stuffy nose, runny nose, nose itching, and sneezing. This medicine was already… Read more

FDA OKs New Steroid-Free Skin Cream for Hand Eczema

July 24, 2025 – The FDA has approved a new treatment as the first and only skin cream for a specific type of hand eczema that affects about 1 in every 10 people globally.The cream, sold… Read more

FDA OKs Moderna’s COVID Shot for Kids, With Limits

July 11, 2025 — The FDA has given full approval to Moderna’s COVID-19 shot, Spikevax, allowing it to be used in children 6 months to 11 years old, with some limits on who can get… Read more

FDA Approves First Oral Treatment for Rare Swelling Disorder

July 8, 2025 – The FDA has approved the first-ever pill to stop attacks of a rare genetic swelling disorder while they’re happening.The drug, known as sebetralstat but sold as Ekterly, is for adults and… Read more

Epkinly: FDA Approves New Bispecific Antibody Option for Relapsed or Refractory Follicular Lymphoma

Epkinly (epcoritamab-bysp) is a type of cancer treatment called a bispecific antibody that helps your immune system find and destroy certain cancer cells by connecting immune cells (T cells) to cancer cells (B cells).Epkinly is… Read more

Zycubo: FDA Approves First Under-the-Skin Shot for Treating Menkes Disease in Children

Zycubo (copper histidinate) is a new under-the-skin injection that the FDA has approved for treating children with a rare genetic condition that affects copper metabolism, known as Menkes disease.Menkes disease is caused by mutations in… Read more

Accrufer: FDA Expands Use of Oral Iron Treatment for Kids Ages 10 and Older

Accrufer (ferric maltol) is an oral capsule approved by the FDA to treat iron deficiency in kids ages 10 years and older.It helps your body absorb iron through your digestive system, which is important for… Read more

Lunsumio Velo: FDA Approves a Convenient Under-the-Skin Shot for Relapsed or Refractory Follicular Lymphoma

Lunsumio Velo  (mosunetuzumab-axgb) is a new under-the-skin (subcutaneous) injection version of the anticancer medicine Lunsumio intravenous infusion.The FDA has granted accelerated approval to Lunsumio Velo for treating adults with follicular lymphoma that has come back (relapsed) or… Read more

FDA Approves Once-Daily Wegovy Pill as the First Oral GLP-1 Medicine for Weight Loss in Adults With Obesity or Overweight

Wegovy (semaglutide) is a prescription medicine that helps with weight loss and lowers the risk of heart problems and liver disease.The FDA has approved its oral pill form to be used alongside a low-calorie diet… Read more